Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Nephrology Physician in Azusa, CA
NPI: 1558377523Primary Practice Location
Azusa Dialysis Center LLC
312 N Azusa Ave, Azusa, CA
Primary Employer
California Kidney Specialists
californiakidneyspecialists.com
HQ Phone
Get M.D. Aamir's Phone Numberphone_androidMobile
Get M.D. Aamir's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1993 - 2026
HI State Medical License
2018 - 2026
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Fellowship • Nephrology
1993 - 1996
St Luke's Hospital
Residency • Internal Medicine
1990 - 1993
Dow University of Health Sciences
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 171 | 393 |
| 2 | 90960Dialysis services (4 or more physician visits per month), patient 20 years of age and older | 113 | 793 |
| 3 | 90961Dialysis services (2-3 physician visits per month), patient 20 years of age and older | 70 | 130 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 68 | 75 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 43 | 118 |
A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (H...
Authors: Abid Rizvi
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
Authors: Marwan Tabbara, Loay Salman, Gabriel Contreras, Abid Rizvi
Journal: Kidney Int Rep
Publication Date: 2020-08-04
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Atrasentan
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: BION-1301 Single Dose, DRUG: Placebo Single Dose, DRUG: BION-1301 Multiple Doses, DRUG: Placebo Multiple Doses
Lead Sponsor: Chinook Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Atrasentan